Decoy Therapeutics Inc. (DCOY)

NASDAQ: DCOY · Real-Time Price · USD

4.110

+0.190 (4.85%)

Jul 31, 2026, 4:00 PM EDT - Market closed

Decoy Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	7.82	10.71	2.43	5.9	12.11	29.21
Cash & Short-Term Investments	7.82	10.71	2.43	5.9	12.11	29.21
Cash Growth	334.87%	339.92%	-58.74%	-51.27%	-58.56%	162.75%
Other Receivables	-	-	-	-	1.61	-
Total Trade Receivables	-	-	-	-	1.61	-
Other Current Assets	0.54	0.28	0.55	0.62	0.8	0.95
Total Current Assets	8.36	10.99	2.99	6.52	14.52	30.16
Net Property, Plant & Equipment	0.04	0.04	-	-	-	-
Goodwill	-	-	-	-	-	8.87
Other Long-Term Assets	0.03	0.03	0.04	0.07	0.13	1.8
Total Assets	8.42	11.06	3.02	6.59	14.65	40.83

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	0.94	0.94	0.94	0.6	2.86	1.54
Accrued Expenses	0.24	0.86	0.35	0.41	1.41	0.57
Short-Term Debt	-	-	0.22	0.29	-	-
Unearned Revenue	3.23	3.23	-	-	-	-
Other Current Liabilities	0.14	0.14	-	-	-	-
Total Current Liabilities	4.55	5.17	1.51	1.3	4.27	2.11
Total Liabilities	4.55	5.17	1.51	1.3	4.27	2.11

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0	0	0	0	0	0
Additional Paid-in Capital	100.54	100.33	83.44	81.64	74.19	70.92
Retained Earnings	-96.67	-94.44	-81.92	-76.35	-63.81	-32.2
Shareholders' Equity	3.88	5.89	1.51	5.29	10.38	38.72
Total Liabilities & Equity	8.42	11.06	3.02	6.59	14.65	40.83

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	-	0	0.22	0.29	0	0
Net Cash (Debt)	7.82	10.71	2.21	5.61	12.11	29.21
Net Cash Growth	363.81%	384.03%	-60.56%	-53.66%	-58.56%	174.53%
Net Cash Per Share	31.11	110.45	27.59	-	-	-
Book Value	3.88	5.89	1.51	5.29	10.38	38.72
Book Value Per Share	15.42	60.73	18.85	-	-	-
Tangible Book Value	3.88	5.89	1.51	5.29	10.38	29.86
Tangible Book Value Per Share	15.42	60.73	18.85	-	-	-